BioFireĀ® Joint Infection Panel for Samples Other than Synovial Fluid
2024

BioFire Joint Infection Panel for Non-Synovial Fluid Samples

Sample size: 48 publication Evidence: moderate

Author Information

Author(s): Benvenuto Nicola, Di Bella Stefano, Principe Luigi, Luppino Diego, Conti Jacopo, Costantino Venera, Di Santolo Manuela, Busetti Marina, Luzzati Roberto, Zerbato Verena

Primary Institution: Trieste University Hospital

Hypothesis

This study aimed to assess the performance of the BioFireĀ® Joint Infection Panel (BF-JIP) in analysing non-synovial fluid samples.

Conclusion

The BF-JIP is a valuable tool for accurate pathogen detection in various clinical samples, offering the additional advantage of being a rapid method.

Supporting Evidence

  • The BF-JIP showed high concordance (85.4%) and enhanced detection (4.3%) compared to culture methods.
  • The BF-JIP demonstrated its highest performance with cerebrospinal fluid, achieving 100% accuracy.
  • In patients undergoing antibiotic therapy, the BF-JIP maintained high performance rates.

Takeaway

The BioFire test helps doctors quickly find out what germs are making people sick, even when they don't have the usual fluid samples.

Methodology

A retrospective cohort study was conducted on hospitalized adults with non-synovial fluid samples tested by both BF-JIP and traditional culture methods.

Limitations

The study is limited by its single-centre design, small sample size, and lack of comprehensive assessment of the clinical impact of BF-JIP.

Participant Demographics

The cohort comprised predominantly male patients (53%), with a median age of 63 years.

Digital Object Identifier (DOI)

10.3390/antibiotics13121198

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication